Denison Mines stock jumps nearly 11% as Phoenix uranium project nears build decision
2 January 2026
2 mins read

Denison Mines stock jumps nearly 11% as Phoenix uranium project nears build decision

NEW YORK, January 2, 2026, 10:05 ET — Regular session

  • Denison Mines shares climbed after the company said it is ready to start construction on its Phoenix ISR uranium mine, pending final approvals.
  • Denison lifted its post-investment initial capital estimate for Phoenix to about C$600 million.
  • Investors are watching for a federal licence decision in Canada and the company’s final investment decision timeline.

Denison Mines rose 10.9% to $2.95 in morning trade on Friday after the uranium developer said it is ready to make a final investment decision and begin construction on its flagship Phoenix project, while raising its upfront build budget.

The update matters now because Phoenix is moving from planning into execution, a phase where timelines and budgets tend to drive stock moves more than long-range resource estimates.

It also puts the next catalyst squarely on regulators: Denison needs federal sign-off in Canada before it can break ground, and the company is pointing to early 2026 as a decision window.

Denison said it is ready to make a final investment decision — the formal go-ahead to build — and commence construction of the Phoenix in-situ recovery (ISR) mine after receiving final regulatory approvals. ISR is a mining method that circulates solution through the ore body and pumps it to the surface, rather than digging an open pit.

The company reiterated an expected two-year construction schedule and said first production remains targeted for mid-2028 if approvals to commence construction are received in the first quarter of 2026.

Denison raised its post-FID initial capital estimate — the upfront capital expenditure, or capex — to about C$600 million, and said the budget includes about C$65 million in contingency and owners’ reserves. The company said the revised figure is about 20% higher than its 2023 feasibility study after adjusting for inflation. 1

“Denison stands ready to make a final investment decision and commence construction of the Phoenix ISR mine,” President and Chief Executive David Cates said. 1

Denison said the Canadian Nuclear Safety Commission’s two-part public hearing on its environmental assessment and construction licence concluded on Dec. 11, and it is awaiting a decision. The company also said Saskatchewan has authorized certain early earthworks such as vegetation removal and site drainage.

On project economics, Denison said its base-case after-tax net present value — a way of translating future cash flows into today’s dollars — is about C$1.57 billion at an 8% discount rate under the updated capex, while after-tax internal rate of return, a profitability metric, is 73%.

Uranium-linked stocks were broadly higher on Friday, with Cameco up 6.7%, Uranium Energy up 9.5% and Energy Fuels up 9.5%. The Global X Uranium ETF rose 5.7% and the Sprott Uranium Miners ETF gained 7.3%.

Traders will focus next on the federal licence decision and on whether Denison locks in construction contracts and a final investment decision on the schedule it outlined. Denison said its updated analysis also reflects higher long-term uranium pricing assumptions, citing a UxC month-end term price estimate of $86 per pound of U3O8 (uranium oxide) as of Dec. 31, 2025. 1

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Alphabet stock rises to start 2026 as analysts flag AI-search tailwinds for GOOG
Previous Story

Alphabet stock rises to start 2026 as analysts flag AI-search tailwinds for GOOG

Strategy (MSTR) stock rises after preferred dividend rate lifted to 11% as bitcoin steadies
Next Story

Strategy (MSTR) stock rises after preferred dividend rate lifted to 11% as bitcoin steadies

Go toTop